| Year |
Citation |
Score |
| 2023 |
Pang Y, Zhou S, Zumbo P, Betel D, Cisse B. TCF12 Deficiency Impairs the Proliferation of Glioblastoma Tumor Cells and Improves Survival. Cancers. 15. PMID 37046694 DOI: 10.3390/cancers15072033 |
0.364 |
|
| 2021 |
Zhou S, Cisse B. Regulation of Microglia for the Treatment of Glioma. World Neurosurgery. 154: 222-227. PMID 34583499 DOI: 10.1016/j.wneu.2021.06.107 |
0.413 |
|
| 2017 |
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim JH, Gorge E, Yanowitch R, Cope W, Vartanian E, Xu R, Zhang T, Pisapia D, Xiang J, Huse J, et al. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. The Journal of Clinical Investigation. PMID 28394259 DOI: 10.1172/Jci86443 |
0.421 |
|
| 2016 |
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K, Cisse B, Haddock S, Huse JT, Pisapia DJ, Chan TA, et al. Malignant astrocytic tumor progression potentiated by JAK-mediated recruitment of myeloid cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28039266 DOI: 10.1158/1078-0432.Ccr-16-1508 |
0.301 |
|
| 2010 |
Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity. 33: 905-16. PMID 21145760 DOI: 10.1016/J.Immuni.2010.11.023 |
0.32 |
|
| 2008 |
Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, Locksley R, Holmberg D, Zweier C, den Hollander NS, Kant SG, Holter W, Rauch A, Zhuang Y, Reizis B. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell. 135: 37-48. PMID 18854153 DOI: 10.1016/J.Cell.2008.09.016 |
0.616 |
|
| Show low-probability matches. |